Exelixis | Försäljning

2022Q32023Q32024Q3

	Sales	Ändra		Datum
Acadia Pharmaceuticals	USD 259.6M		9.2M	2024-12
Agios Pharmaceuticals	USD 10.73M		1.77M	2024-12
Amgen	USD 9.09B		583M	2024-12
AstraZeneca	USD 14.89B		1.32B	2024-12
Bayer	EUR 11.73B		1.76B	2024-12
BioMarin Pharmaceutical	USD 747.31M		1.57M	2024-12
Bristol-Myers Squibb	USD 12.34B		450M	2024-12
Cytokinetics	USD 16.93M		16.46M	2024-12
Eisai	JPY 216.14B		20.15B	2024-12
Eli Lilly	USD 13.53B		2.09B	2024-12
Exelixis	USD 566.76M		27.21M	2024-12
Genmab	DKK 64.41B		58.87B	2024-12
Glaxosmithkline	GBP 8.12B		105M	2024-12
Incyte	USD 1.18B		40.83M	2024-12
Ionis Pharmaceuticals	USD 226.58M		92.76M	2024-12
MacroGenics	USD 19.35M		91.35M	2024-12
Merck	USD 15.62B		1.03B	2024-12
Moderna	USD 966M		896M	2024-12
Neurocrine Biosciences	USD 627.7M		5.6M	2024-12
Novartis	USD 13.15B		330M	2024-12
Pfizer	USD 17.76B		61M	2024-12
Sanofi	EUR 11.26B		3.5B	2024-12
Takeda	JPY 1.14T		40B	2024-12
Ultragenyx Pharmaceutical	USD 164.88M		25.38M	2024-12
Xencor	USD 70.02M		59.31M	2024-12

Exelixis Försäljning - Aktuella värden, historiska data, prognoser, statistik, diagram och ekonomisk kalender - Apr 2025.